6190 Cornerstone Ct, East
2 articles with Mesa Biotech
Mesa Biotech Named 2019 Frost & Sullivan Price/Performance Value Leader in Global Influenza Point-of-Care Testing
Mesa Biotech Inc., is a privately held, molecular diagnostic company that developed an affordable and easy to operate polymerase chain reaction testing platform designed specifically for point-of-care infectious disease diagnosis.
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC), today announced it has obtained CE Mark in the European Union (EU) for its Accula™ RSV Test.